UNSPSC 51363503: Barbital/hyoscyamine/hyoscyamus/passion/scopolamine/valerian

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN309. This VA Drug Class (CN309) classifies this compound as belonging to the group SEDATIVES/HYPNOTICS, OTHER.

UNSPSC 51363503 Barbital/hyoscyamine/hyoscyamus/passion/scopolamine/valerian is a Commodity code that shows minimal alignment with recent state and local procurement activity. The single recent opportunity tagged under this code—Seminole County, Florida's IFB for naloxone and drug deactivation systems—involves opioid-overdose reversal agents and harm-reduction equipment unrelated to the sedative, anticholinergic, and herbal compounds the code nominally describes. The mismatch suggests either a data-entry error in the county's procurement system or a fundamental misclassification of the opportunity within the UNSPSC taxonomy.

No additional recent state and local opportunities appear in the source under this code. Seminole County's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, requests 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly delivery to the Seminole County Community Health Building in Sanford, Florida. The procurement requires electronic bid submission, includes drug-free workplace and E-Verify compliance, carries an initial two-year term with a one-year renewal option, and is potentially funded through FEMA. Given the scarcity of relevant recent activity and the clear scope mismatch, this code warrants close attention only if your firm operates in pharmaceutical supply or medical-device distribution and can verify whether Seminole County's categorization reflects an actual procurement pattern or a cataloging error in the county's RFQ system.